Version 2 2021-10-13, 09:33Version 2 2021-10-13, 09:33
Version 1 2019-11-23, 11:50Version 1 2019-11-23, 11:50
journal contribution
posted on 2019-11-23, 11:50authored byDarren Griffith, Maria P. Morgan, Celine J. Marmion
The successful design and synthesis of a novel multifunctional platinum drug candidate with DNA binding, histone deacetylase inhibitory activity and enhanced selectivity for cancer cells are described.
History
Comments
This article is also available from http://pubs.rsc.org
Published Citation
Griffith D, Morgan MP, Marmion CJ. A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity. Chem Commun (Camb). 2009;44:6735-6737